Armata Pharmaceuticals, Inc.: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02

Intravenous use as a QIDP for adjunct treatment of complicated bacteremia caused by Staphylococcus aureus QIDP Designation provides for five years of market exclusivity ...
The Malaysian Reserve

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02

Intravenous use as a QIDP for adjunct treatment of complicated bacteremia caused by Staphylococcus aureus QIDP Designation ...

Armata Pharmaceuticals stock gains on FDA designation

Investing.com -- Armata Pharmaceuticals Inc (NYSE American:ARMP) shares rose 3.1% in premarket trading Monday after the company announced that the U.S. Food and Drug Administration granted Qualified ...